rdf:type |
|
lifeskim:mentions |
umls-concept:C0006935,
umls-concept:C0023566,
umls-concept:C0030685,
umls-concept:C0074517,
umls-concept:C0086418,
umls-concept:C0206427,
umls-concept:C0391871,
umls-concept:C0439844,
umls-concept:C0680255,
umls-concept:C1283071,
umls-concept:C1521828,
umls-concept:C1881065,
umls-concept:C1963578,
umls-concept:C1999244
|
pubmed:issue |
5
|
pubmed:dateCreated |
1983-10-21
|
pubmed:abstractText |
Three forms of subdermal implants containing levonorgestrel are described. These are: capsules, in which the powdered drug is sealed inside of lengths of Medical Grade Silastic tubing; homogeneous rods, in which the drug is uniformly dispersed in Silastic 382 Medical Grade Elastomer; and covered rods, in which a core rod of drug and filler-free polydimethylsiloxane polymer (50:50, Wt:Wt) are sealed inside thin-walled Silastic tubing. Long-term in vivo release rates from human subjects are presented; 6.5 years for capsules, 3.6 years for homogeneous rods and 4 years for covered rods. Sets of six capsules release a decreasing amount of drug through the first few hundred days in situ and after 500 days a fairly constant rate of about 35 micrograms per day is released (2 micrograms/cm). Homogeneous rods deliver a continuously declining amount of drug during the entire time studied. In the first 100 days the release averages 136 micrograms per day from a set of three 3-cm rods (15 micrograms/cm), gradually declining to 30 micrograms per day (3.3 micrograms/cm) from day 800 to day 1300. The covered rods deliver at a constant rate of 17.5 micrograms per day for a 3-cm rod (5.83 micrograms/cm) through 4 years.
|
pubmed:keyword |
http://linkedlifedata.com/resource/pubmed/keyword/Contraception,
http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Agents, Female,
http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Agents, Progestin,
http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive...,
http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Agents--analysis,
http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Implants,
http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Methods,
http://linkedlifedata.com/resource/pubmed/keyword/Family Planning,
http://linkedlifedata.com/resource/pubmed/keyword/Levonorgestrel--administraction and...,
http://linkedlifedata.com/resource/pubmed/keyword/Levonorgestrel--analysis,
http://linkedlifedata.com/resource/pubmed/keyword/Reproductive Control Agents
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0010-7824
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
483-95
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6411428-Capsules,
pubmed-meshheading:6411428-Contraceptives, Oral, Combined,
pubmed-meshheading:6411428-Dimethylpolysiloxanes,
pubmed-meshheading:6411428-Drug Implants,
pubmed-meshheading:6411428-Female,
pubmed-meshheading:6411428-Humans,
pubmed-meshheading:6411428-Levonorgestrel,
pubmed-meshheading:6411428-Norgestrel,
pubmed-meshheading:6411428-Silicones
|
pubmed:year |
1983
|
pubmed:articleTitle |
Release rates of levonorgestrel from Silastic capsules, homogeneous rods and covered rods in humans.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|